News Daily News Frail Older Patients With AF May Fare Better Switching to DOAC Todd Neale August 05, 2025
News Conference News NY Valves 2025 No Benefit of Sentinel Device During TAVI: Updated Meta-analysis Todd Neale July 04, 2025
News Daily News Low Bleeding Risk With Abelacimab in AF Patients Undergoing Invasive Procedures Todd Neale June 10, 2025
News Conference News ESOC 2025 High Residual Risk of Recurrent Stroke Seen in AF Patients on Anticoagulants Todd Neale May 29, 2025
News Daily News Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding L.A. McKeown May 16, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2025 Caitlin E. Cox April 30, 2025
News Conference News EHRA 2025 SWISS-APERO at 3 Years: Hints of Differences Between Amulet, Watchman Emerge Todd Neale April 09, 2025
News Conference News ACC 2025 RIVAWAR: Rivaroxaban as Safe and Effective as Warfarin for LV Thrombus in MI Michael O'Riordan April 02, 2025
News Conference News ACC 2025 Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT Caitlin E. Cox March 29, 2025
News Daily News Biomarker-Based Risk Score Better Predicts Stroke in AF Than Clinical Tools Todd Neale March 19, 2025
News Daily News SCAD Story Fleshed Out by Clues About Causes, Treatment Risks Yael L. Maxwell March 13, 2025
News Conference News CRT 2025 Need for Rethink of Discharge Medications After LAA Closure? EMERGE L.A. McKeown March 12, 2025
News Conference News CRT 2025 SMART: Small Aortic Annuli Still Fare Best With Self-Expandable Valves at 2 Years L.A. McKeown March 10, 2025
News Daily News DOACs Reduce Stroke, Increase Bleeding in ICH Survivors With AF Todd Neale March 06, 2025
News Daily News Coverage and Use of Impella and Watchman: A Tale of Four Countries Michael O'Riordan March 04, 2025
News Daily News Danish Analysis Updates Stroke and MI Risks of Contemporary Contraceptives L.A. McKeown March 03, 2025
News Daily News More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin L.A. McKeown February 14, 2025